New Lipid Therapy Shows Promise in Reversing Age-Related Vision Decline

Vision loss is one of the most common effects of aging, which often makes it harder for older adults to read or see clearly in dim light. Now, scientists at the University of California, Irvine, are exploring a potential therapy that could slow — or even reverse — age-related eye degeneration and help prevent diseases such as macular degeneration.

In collaboration with the Polish Academy of Sciences and the University of Potsdam's Health and Medical School in Germany, the research team published their findings in Science Translational Medicine. Their study suggests that supplementing with certain fatty acids may restore vision that has deteriorated with age.

The work centers on a known aging biomarker — the ELOVL2 gene, which helps produce very long-chain polyunsaturated fatty acids and DHA, an essential omega-3 fatty acid crucial for retinal health. As people age, lipid metabolism changes reduce these fatty acids in the retina, impairing vision.

Previous studies found that enhancing ELOVL2 activity in older mice boosted DHA levels and improved eyesight. This new study achieved similar benefits without directly targeting the gene: when researchers injected elderly mice with a specific polyunsaturated fatty acid, their visual function significantly improved.

Importantly, the same effect was not seen with DHA alone — echoing previous doubts about DHA's standalone benefits. On a molecular level, the results suggest that this particular lipid may actually reverse some hallmarks of aging.

The research team is also looking beyond the eye. A related collaboration with UC San Diego indicates that lipid metabolism may play a role in immune system aging as well. This raises the exciting possibility that therapies designed to protect vision might one day also help rejuvenate immune function.